These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7560661)

  • 61. Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.
    Newnham DM; Grove A; McDevitt DG; Lipworth BJ
    Thorax; 1995 May; 50(5):497-504. PubMed ID: 7597661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
    Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
    Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients.
    Tan KS; Grove A; McLean A; Gnosspelius Y; Hall IP; Lipworth BJ
    Am J Respir Crit Care Med; 1997 Jul; 156(1):28-35. PubMed ID: 9230722
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial.
    Akpinarli A; Tuncer A; Saraçlar Y; Sekerel BE; Kalayci O
    Arch Dis Child; 1999 Jul; 81(1):45-8. PubMed ID: 10373134
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
    Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
    Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
    Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
    Orgel HA; Kemp JP; Tinkelman DG; Webb DR
    J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nebulised fenoterol compared with metered aerosol.
    Melville C; Phelan PD; Landau LI
    Arch Dis Child; 1985 Mar; 60(3):257-9. PubMed ID: 3985659
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
    Lötvall J; Mellén A; Arvidsson P; Palmqvist M; Radielovic P; Kottakis J; Pfister P
    Can Respir J; 1999; 6(5):412-6. PubMed ID: 10572207
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma.
    Bauer K; Dietersdorfer F; Sertl K; Kaik B; Kaik G
    Clin Pharmacol Ther; 1993 Jan; 53(1):76-83. PubMed ID: 8422745
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety of formoterol after cumulative dosing via Easyhaler and Aerolizer.
    Randell J; Saarinen A; Walamies M; Vahteristo M; Silvasti M; Lähelmä S
    Respir Med; 2005 Dec; 99(12):1485-93. PubMed ID: 16226024
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).
    Pearlman DS; Eckerwall G; McLaren J; Lamarca R; Puu M; Gilbert I; Jorup C; Sandin K; Lanz MJ
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):489-499.e1. PubMed ID: 28256307
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nebulized fenoterol in severe asthma: determinants of the dose response.
    Mitchell CA; Armstrong JG; Bartholomew MA; Scicchitano R
    Eur J Respir Dis; 1983 Jul; 64(5):340-6. PubMed ID: 6884446
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
    Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB; Simons FE
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.